One example of this was a 2016 meta-analysis by Ivan et al. in which grade 3 astrocytoma were included with IDH-wildtype GBMs and thus OS was reported as higher at 14.2 months [14]. This evidence concerns the gene IDH1 and astrocytoma (excluding glioblastoma).